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This case report describes an immune-competent patient with acute upper extremity ischemia caused by thromboem-
bolism from an Aspergillus-infected ascending aortic pseudoaneurysm. Efforts to identify the source of an acute arterial
thromboembolic occlusion should be made, and a high index of suspicion for mycotic infection should be maintained in
patients with an atypical presentation, such as fevers of unknown origin. Additional measures, such as pathologic
examination of thromboembolic debris, blood cultures, and positron emission tomography, should be performed to
identify the etiology in these unexplained situations. (J Vasc Surg Cases 2015;1:94-6.)Mycotic thromboembolization is a rare cause of acute
large-vessel arterial occlusion. This case report describes
an immune-competent patient with acute upper extremity
ischemia caused by embolization from an Aspergillus-
infected ascending aortic pseudoaneurysm. Signed consent
was obtained from the patient for publication.
CASE REPORT
A 57-year-old man, who had undergone coronary artery
bypass grafting (CABG) 5 years prior to presentation, was
admitted to an outside facility with a 4-day history of fevers and
a 24-hour history of numbness and tingling in his right upper ex-
tremity. The patient was noted to have an absent radial pulse.
Duplex ultrasound imaging demonstrated a brachial artery occlu-
sion. The patient was transferred to our institution for further eval-
uation and treatment.
Upon arrival, the patient was taken emergently to the oper-
ating room for thromboembolectomy. A Fogarty catheter was
used to remove w5 cm of normal-appearing clot after multiple
passes, with subsequent return of a strong radial pulse, a weak
ulnar pulse, and brisk capillary reﬁll in all ﬁngers. The patient
was maintained on intravenous systemic anticoagulation.
A postoperative electrocardiogram demonstrated sinus
rhythm. A transthoracic echocardiogram was negative for an
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://dx.doi.org/10.1016/j.jvsc.2015.03.010study likewise conﬁrmed the absence of vegetation or clot within
the heart. A computed tomography (CT) angiogram of the chest
demonstrated a 7.2-cm saccular pseudoaneurysm of the ascending
aorta, which had not been seen on either echocardiogram (Figs 1
and 2).
Pathologic examination of the clot using hematoxylin and
eosin and Grocott methenamine silver stains unexpectedly found
hyphae with parallel and acute angle branching, morphologically
consistent with Aspergillus (Fig 3). Voriconazole systemic anti-
fungal therapy was initiated.
Human immunodeﬁciency virus serologic testing was negative.
The results of a complete blood count with differential were within
expected limits, and blood cultures were negative for growth. A
head CT was negative for disseminated infection, and the chest
CT likewise had not shown pulmonary disease. An ophthalmologic
examination was negative for fungal endophthalmitis.
The patient was transferred to a cardiac surgery unit with addi-
tional capabilities. A positron emission tomography (PET) scan
conﬁrmed localized infection to the ascending aortic pseudoaneur-
ysm. After axillary cannulation and initiation of cardiopulmonary
bypass, a sternotomy was performed under deep hypothermic
circulatory arrest. Cardioprotection after aortic cross-clamping
was achieved selectively through a proximal vein graft and the cor-
onary ostia. The aortic pseudoaneurysm was opened primarily, and
cavitary thrombectomy was performed. The infection and false
aneurysm appeared to originate from a proximal vein graft anasto-
motic suture line. After extensive débridement and irrigation of the
pseudoaneurysm, a large aortic patch repair using heterologous
bovine pericardium was performed for complete exclusion.
The patient was discharged home in satisfactory condition. He
had not demonstrated any signs of recurrence upon initial follow-
up, and will be followed annually with contrasted CT scans of the
chest. The patient has been maintained on life-long voriconazole
antifungal therapy, aspirin, and warfarin.
DISCUSSION
This is a unique case ofAspergillus endoaortitis and aortic
pseudoaneurysmproducing acute limb ischemia secondary to
thromboembolization in an immune-competent patient who
did not have any cardiovascular prosthetic implants. Upon
reﬂection, the patient recalled an event w3 years prior
Fig 1. Axial view of ascending aortic pseudoaneurysm
(white arrow).
Fig 2. Sagittal view of ascending aortic pseudoaneurysm
(white arrow).
Fig 3. Grocott methenamine silver stain at original
magniﬁcation 20 delineated hyphae with parallel and acute angle
branching consistent with Aspergillus.
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respiratory symptoms. In theoutsideenvironmentAspergillus
is known to be ubiquitous and can be internalized by inhala-
tion.1-4Themost common source forAspergillus endoaortitis
is pulmonary,5,6 which represents a possible source of infec-
tion in this patient. In addition, the patient had undergone
CABG; thus, infection at the time of CABG represents
another possible source. The presence of an Aspergillus-
infected aortic pseudoaneurysm after CABG is extremely
rare but can occur at an anastomotic or aortic cannulation
site.7,8 Indeed, some have suggested that, despite its rarity,
aortic mycotic aneurysm and fungal endoaortitis be consid-
ered in any patient who presents with fevers of unknown
origin who had previously undergone an invasive cardiovas-
cular procedure.4,9,10
Aspergillus is the most common cause of fungal
endoaortitis,11 and although Aspergillus endoaortitis isusually associated with an immunocompromised state,4,6
it can rarely occur in immune-competent patients.2,3 The
most common source of immunocompromise associated
with Aspergillus endoaortitis is chemotherapy,12 with other
common causes including immunosuppression,6,13,14
diabetes,15 and acquired immune deﬁciency syndrome.1
This patient had no known history of cancer, immunosup-
pressive therapy, diabetes, or any other recognized cause of
immunocompromise.
Acute arterial thromboembolic occlusion of the ex-
tremity is often associated with cardiac arrhythmias, left
ventricular aneurysm, and valvular heart disease.1 In this
patient, however, the echocardiograms did not demon-
strate any intracardiac abnormalities that could have
produced an arterial embolism. Moreover, Aspergillus
embolization from an aortic or cardiac source is usually
associated with infection of prosthetic material, such as a
prosthetic heart valve or an aortic graft,4,5 but this patient
had no prior cardiovascular prosthetic implants of any kind.
In the setting of embolization from an unknown source,
pathologic examination of thromboembolic debris should
be considered.16 After thromboembolectomy, if an aneu-
rysm is discovered to be the source, then PET can conﬁrm
aneurysm infection based on uptake and can delineate
other locations of active infection.17
Systemic anticoagulation after thromboembolism
resulting in acute ischemia has been supported by level 1
evidence.18 This notion has been reiterated in current prac-
tice guidelines by the Inter-Society Consensus for the
Management of Peripheral Arterial Disease (TASC II)
and by the American College of Chest Physicians.19,20
Moreover, in the setting of arterial embolization, systemic
anticoagulation reduces the chance of future embolization
by up to 75% and can decrease long-term mortality.18
Although the combination of systemic anticoagulation
with antiplatelet therapy has been questioned in symptom-
atic peripheral arterial disease,20 administration of a
combination of systemic anticoagulation with antiplatelet
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thromboembolism, except in situations where speciﬁc
contraindications exist.21
Upon diagnosis of a mycotic aortic pseudoaneurysm,
prompt surgical intervention should be performed.8 Repair
options include autologous pericardial patch, heterologous
bovine pericardial patch, cryopreserved allograft, or a syn-
thetic graft if the above are unavailable.8,12,22,23 Surgical
intervention to remove the infected thromboembolic
source is the treatment of choice,8,11,12,15 although Asper-
gillus endoaortitis is often fatal even with both medical and
surgical intervention.2,11,13
Even though patients with mycotic aneurysms of the
aorta often present with fevers,9 blood cultures are often
negative in cases of fungal infection, and cultures that are
persistently negative should alert the clinician that a fungal
rather than bacterial infection may be present.5,7,10 Indeﬁ-
nite systemic antifungal therapy plays a prominent role in
the medical treatment of patients with Aspergillus endoaor-
titis.13,14 Voriconazole has been shown to have a superior
response compared with amphotericin B, and if adverse ef-
fects develop, then voriconazole can be transitioned to itra-
conazole.24 Once the diagnosis of invasive aspergillosis has
been made, systemic antifungal therapy using voriconazole
should be initiated.24
CONCLUSIONS
Efforts should bemade to identify the source of an acute
arterial thromboembolic occlusion, and a high index of
suspicion for mycotic infection should be maintained in
patients with an atypical presentation, such as fevers of
unknown origin. Additional measures, such as pathologic
examination of thromboembolic debris, blood cultures,
and PET, should be performed to identify the etiology in
these unexplained situations. Surgical intervention to
remove the infected thromboembolic source is the treatment
of choice, although Aspergillus endoaortitis is often fatal
even with both medical and surgical intervention. Indeﬁnite
systemic antifungal therapy plays a prominent role in the
medical treatment of patients with Aspergillus endoaortitis,
whether or not surgical intervention is possible.
We acknowledge Dr Elizabeth Arze, East Tennessee
State University Department of Pathology, Dr Melanie
Davidson, Mountain States Health Alliance Department
of Cardiology, and Dr Dima Youssef, Mountain States
Health Alliance Department of Infectious Disease.
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